ANI Pharma (ANIP) Tops Q4 EPS by 8c

ANI Pharma (NASDAQ: ANIP) reported Q4 EPS of $0.76, $0.08 better than the analyst estimate of $0.68. Revenue for the quarter came in at $94.2 million versus the consensus estimate of $85.19 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim